0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Flu Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-35P5648
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Flu Diagnosis Market Insights Forecast to 2028
BUY CHAPTERS

Flu Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-35P5648
Report
October 2024
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Flu Diagnosis - Market Size

The global market for Flu Diagnosis was estimated to be worth US$ 1657 million in 2023 and is forecast to a readjusted size of US$ 2426.7 million by 2030 with a CAGR of 5.6% during the forecast period 2024-2030

Flu Diagnosis - Market

Flu Diagnosis - Market

Flu diagnosis refers to the process of determining whether an individual is infected with influenza, commonly known as the flu. The diagnosis is typically done by healthcare professionals using various methods and tests to identify the presence of the influenza virus or its components in a patient’s body.
The global flu diagnosis market encompasses a wide range of products and services aimed at identifying and diagnosing influenza infections worldwide. This market is driven by the prevalence of influenza, the need for accurate and timely diagnosis, and the ongoing technological advancements in diagnostic testing. Several key factors contribute to the dynamics of the global flu diagnosis market:
Diagnostic Tests: The market includes a variety of diagnostic tests used to detect influenza viruses in patient samples. These tests may include rapid antigen tests, nucleic acid amplification tests (NAATs), such as PCR-based assays, and serological tests. Ongoing innovation in test formats, sensitivity, and specificity is a key driver of market growth.
Point-of-Care (POC) Testing: POC testing for flu diagnosis involves the use of rapid diagnostic tests that can be performed at or near the site of patient care. The demand for rapid and accurate POC testing solutions continues to shape the market, with an emphasis on delivering timely results for informed decision-making.
Laboratory Equipment and Consumables: This segment includes the instrumentation, reagents, and consumables used in laboratory settings for conducting flu diagnostic tests. Market growth in this segment is driven by the ongoing demand for high-throughput testing solutions and the need for efficient laboratory workflows.
Software and Informatics Solutions: The flu diagnosis market also encompasses software and informatics solutions designed to streamline data management, analysis, and reporting related to flu testing. These solutions play a crucial role in enhancing laboratory efficiency and supporting data-driven decision-making.
Distribution and Service Providers: Companies involved in the distribution, sales, and servicing of flu diagnostic products and services contribute to the accessibility and availability of these products in healthcare facilities and laboratories globally.
By region, the market is characterized by varying levels of healthcare infrastructure, regulatory landscapes, and disease prevalence, all of which influence market dynamics and growth opportunities.
Prominent companies operating in the global flu diagnosis market focus on product innovation, strategic collaborations, and geographic expansion to address the evolving needs of healthcare providers and patients. Additionally, efforts are ongoing to align with healthcare policies, regulatory requirements, and public health strategies that influence the diagnosis and management of influenza.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Flu Diagnosis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Flu Diagnosis by region & country, by Type, and by Application.
The Flu Diagnosis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Diagnosis.
Market Segmentation

Scope of Flu Diagnosis - Market Report

Report Metric Details
Report Name Flu Diagnosis - Market
Forecasted market size in 2030 US$ 2426.7 million
CAGR 5.6%
Forecasted years 2024 - 2030
Segment by Type:
  • Traditional Diagnostic Tests
  • Molecular Diagnostic Tests
  • Other
Segment by Application
  • Hospitals
  • Clinical Laboratories
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Quidel Corporation, Thermo Fisher Scientific, Abbott Laboratories, DiaSorin SpA, Luminex Corporation, Meridian Bioscience, GenMark Diagnostics, Sekisui Diagnostics, Danaher Corporation, Siemens Healthineers, Cepheid Inc., Bio-Rad Laboratories, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Flu Diagnosis manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Flu Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Flu Diagnosis in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Flu Diagnosis - Market size in 2030?

Ans: The Flu Diagnosis - Market size in 2030 will be US$ 2426.7 million.

Who are the main players in the Flu Diagnosis - Market report?

Ans: The main players in the Flu Diagnosis - Market are Roche, Quidel Corporation, Thermo Fisher Scientific, Abbott Laboratories, DiaSorin SpA, Luminex Corporation, Meridian Bioscience, GenMark Diagnostics, Sekisui Diagnostics, Danaher Corporation, Siemens Healthineers, Cepheid Inc., Bio-Rad Laboratories, Inc.

What are the Application segmentation covered in the Flu Diagnosis - Market report?

Ans: The Applications covered in the Flu Diagnosis - Market report are Hospitals, Clinical Laboratories, Other

What are the Type segmentation covered in the Flu Diagnosis - Market report?

Ans: The Types covered in the Flu Diagnosis - Market report are Traditional Diagnostic Tests, Molecular Diagnostic Tests, Other

1 Market Overview
1.1 Flu Diagnosis Product Introduction
1.2 Global Flu Diagnosis Market Size Forecast
1.3 Flu Diagnosis Market Trends & Drivers
1.3.1 Flu Diagnosis Industry Trends
1.3.2 Flu Diagnosis Market Drivers & Opportunity
1.3.3 Flu Diagnosis Market Challenges
1.3.4 Flu Diagnosis Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Flu Diagnosis Players Revenue Ranking (2023)
2.2 Global Flu Diagnosis Revenue by Company (2019-2024)
2.3 Key Companies Flu Diagnosis Manufacturing Base Distribution and Headquarters
2.4 Key Companies Flu Diagnosis Product Offered
2.5 Key Companies Time to Begin Mass Production of Flu Diagnosis
2.6 Flu Diagnosis Market Competitive Analysis
2.6.1 Flu Diagnosis Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Flu Diagnosis Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu Diagnosis as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Traditional Diagnostic Tests
3.1.2 Molecular Diagnostic Tests
3.1.3 Other
3.2 Global Flu Diagnosis Sales Value by Type
3.2.1 Global Flu Diagnosis Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Flu Diagnosis Sales Value, by Type (2019-2030)
3.2.3 Global Flu Diagnosis Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinical Laboratories
4.1.3 Other
4.2 Global Flu Diagnosis Sales Value by Application
4.2.1 Global Flu Diagnosis Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Flu Diagnosis Sales Value, by Application (2019-2030)
4.2.3 Global Flu Diagnosis Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Flu Diagnosis Sales Value by Region
5.1.1 Global Flu Diagnosis Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Flu Diagnosis Sales Value by Region (2019-2024)
5.1.3 Global Flu Diagnosis Sales Value by Region (2025-2030)
5.1.4 Global Flu Diagnosis Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Flu Diagnosis Sales Value, 2019-2030
5.2.2 North America Flu Diagnosis Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Flu Diagnosis Sales Value, 2019-2030
5.3.2 Europe Flu Diagnosis Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Flu Diagnosis Sales Value, 2019-2030
5.4.2 Asia Pacific Flu Diagnosis Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Flu Diagnosis Sales Value, 2019-2030
5.5.2 South America Flu Diagnosis Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Flu Diagnosis Sales Value, 2019-2030
5.6.2 Middle East & Africa Flu Diagnosis Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Flu Diagnosis Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Flu Diagnosis Sales Value
6.3 United States
6.3.1 United States Flu Diagnosis Sales Value, 2019-2030
6.3.2 United States Flu Diagnosis Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Flu Diagnosis Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Flu Diagnosis Sales Value, 2019-2030
6.4.2 Europe Flu Diagnosis Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Flu Diagnosis Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Flu Diagnosis Sales Value, 2019-2030
6.5.2 China Flu Diagnosis Sales Value by Type (%), 2023 VS 2030
6.5.3 China Flu Diagnosis Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Flu Diagnosis Sales Value, 2019-2030
6.6.2 Japan Flu Diagnosis Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Flu Diagnosis Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Flu Diagnosis Sales Value, 2019-2030
6.7.2 South Korea Flu Diagnosis Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Flu Diagnosis Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Flu Diagnosis Sales Value, 2019-2030
6.8.2 Southeast Asia Flu Diagnosis Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Flu Diagnosis Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Flu Diagnosis Sales Value, 2019-2030
6.9.2 India Flu Diagnosis Sales Value by Type (%), 2023 VS 2030
6.9.3 India Flu Diagnosis Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Profile
7.1.2 Roche Main Business
7.1.3 Roche Flu Diagnosis Products, Services and Solutions
7.1.4 Roche Flu Diagnosis Revenue (US$ Million) & (2019-2024)
7.1.5 Roche Recent Developments
7.2 Quidel Corporation
7.2.1 Quidel Corporation Profile
7.2.2 Quidel Corporation Main Business
7.2.3 Quidel Corporation Flu Diagnosis Products, Services and Solutions
7.2.4 Quidel Corporation Flu Diagnosis Revenue (US$ Million) & (2019-2024)
7.2.5 Quidel Corporation Recent Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Profile
7.3.2 Thermo Fisher Scientific Main Business
7.3.3 Thermo Fisher Scientific Flu Diagnosis Products, Services and Solutions
7.3.4 Thermo Fisher Scientific Flu Diagnosis Revenue (US$ Million) & (2019-2024)
7.3.5 Abbott Laboratories Recent Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Profile
7.4.2 Abbott Laboratories Main Business
7.4.3 Abbott Laboratories Flu Diagnosis Products, Services and Solutions
7.4.4 Abbott Laboratories Flu Diagnosis Revenue (US$ Million) & (2019-2024)
7.4.5 Abbott Laboratories Recent Developments
7.5 DiaSorin SpA
7.5.1 DiaSorin SpA Profile
7.5.2 DiaSorin SpA Main Business
7.5.3 DiaSorin SpA Flu Diagnosis Products, Services and Solutions
7.5.4 DiaSorin SpA Flu Diagnosis Revenue (US$ Million) & (2019-2024)
7.5.5 DiaSorin SpA Recent Developments
7.6 Luminex Corporation
7.6.1 Luminex Corporation Profile
7.6.2 Luminex Corporation Main Business
7.6.3 Luminex Corporation Flu Diagnosis Products, Services and Solutions
7.6.4 Luminex Corporation Flu Diagnosis Revenue (US$ Million) & (2019-2024)
7.6.5 Luminex Corporation Recent Developments
7.7 Meridian Bioscience
7.7.1 Meridian Bioscience Profile
7.7.2 Meridian Bioscience Main Business
7.7.3 Meridian Bioscience Flu Diagnosis Products, Services and Solutions
7.7.4 Meridian Bioscience Flu Diagnosis Revenue (US$ Million) & (2019-2024)
7.7.5 Meridian Bioscience Recent Developments
7.8 GenMark Diagnostics
7.8.1 GenMark Diagnostics Profile
7.8.2 GenMark Diagnostics Main Business
7.8.3 GenMark Diagnostics Flu Diagnosis Products, Services and Solutions
7.8.4 GenMark Diagnostics Flu Diagnosis Revenue (US$ Million) & (2019-2024)
7.8.5 GenMark Diagnostics Recent Developments
7.9 Sekisui Diagnostics
7.9.1 Sekisui Diagnostics Profile
7.9.2 Sekisui Diagnostics Main Business
7.9.3 Sekisui Diagnostics Flu Diagnosis Products, Services and Solutions
7.9.4 Sekisui Diagnostics Flu Diagnosis Revenue (US$ Million) & (2019-2024)
7.9.5 Sekisui Diagnostics Recent Developments
7.10 Danaher Corporation
7.10.1 Danaher Corporation Profile
7.10.2 Danaher Corporation Main Business
7.10.3 Danaher Corporation Flu Diagnosis Products, Services and Solutions
7.10.4 Danaher Corporation Flu Diagnosis Revenue (US$ Million) & (2019-2024)
7.10.5 Danaher Corporation Recent Developments
7.11 Siemens Healthineers
7.11.1 Siemens Healthineers Profile
7.11.2 Siemens Healthineers Main Business
7.11.3 Siemens Healthineers Flu Diagnosis Products, Services and Solutions
7.11.4 Siemens Healthineers Flu Diagnosis Revenue (US$ Million) & (2019-2024)
7.11.5 Siemens Healthineers Recent Developments
7.12 Cepheid Inc.
7.12.1 Cepheid Inc. Profile
7.12.2 Cepheid Inc. Main Business
7.12.3 Cepheid Inc. Flu Diagnosis Products, Services and Solutions
7.12.4 Cepheid Inc. Flu Diagnosis Revenue (US$ Million) & (2019-2024)
7.12.5 Cepheid Inc. Recent Developments
7.13 Bio-Rad Laboratories, Inc.
7.13.1 Bio-Rad Laboratories, Inc. Profile
7.13.2 Bio-Rad Laboratories, Inc. Main Business
7.13.3 Bio-Rad Laboratories, Inc. Flu Diagnosis Products, Services and Solutions
7.13.4 Bio-Rad Laboratories, Inc. Flu Diagnosis Revenue (US$ Million) & (2019-2024)
7.13.5 Bio-Rad Laboratories, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Flu Diagnosis Industrial Chain
8.2 Flu Diagnosis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Flu Diagnosis Sales Model
8.5.2 Sales Channel
8.5.3 Flu Diagnosis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Flu Diagnosis Market Trends
    Table 2. Flu Diagnosis Market Drivers & Opportunity
    Table 3. Flu Diagnosis Market Challenges
    Table 4. Flu Diagnosis Market Restraints
    Table 5. Global Flu Diagnosis Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Flu Diagnosis Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Flu Diagnosis Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Flu Diagnosis Product Type
    Table 9. Key Companies Time to Begin Mass Production of Flu Diagnosis
    Table 10. Global Flu Diagnosis Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu Diagnosis as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Flu Diagnosis Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Flu Diagnosis Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Flu Diagnosis Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Flu Diagnosis Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Flu Diagnosis Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Flu Diagnosis Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Flu Diagnosis Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Flu Diagnosis Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Flu Diagnosis Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Flu Diagnosis Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Flu Diagnosis Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Flu Diagnosis Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Flu Diagnosis Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Flu Diagnosis Sales Value by Region (2019-2024) & (%)
    Table 27. Global Flu Diagnosis Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Flu Diagnosis Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Flu Diagnosis Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Flu Diagnosis Sales Value, (2025-2030) & (US$ Million)
    Table 31. Roche Basic Information List
    Table 32. Roche Description and Business Overview
    Table 33. Roche Flu Diagnosis Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Flu Diagnosis Business of Roche (2019-2024)
    Table 35. Roche Recent Developments
    Table 36. Quidel Corporation Basic Information List
    Table 37. Quidel Corporation Description and Business Overview
    Table 38. Quidel Corporation Flu Diagnosis Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Flu Diagnosis Business of Quidel Corporation (2019-2024)
    Table 40. Quidel Corporation Recent Developments
    Table 41. Thermo Fisher Scientific Basic Information List
    Table 42. Thermo Fisher Scientific Description and Business Overview
    Table 43. Thermo Fisher Scientific Flu Diagnosis Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Flu Diagnosis Business of Thermo Fisher Scientific (2019-2024)
    Table 45. Thermo Fisher Scientific Recent Developments
    Table 46. Abbott Laboratories Basic Information List
    Table 47. Abbott Laboratories Description and Business Overview
    Table 48. Abbott Laboratories Flu Diagnosis Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Flu Diagnosis Business of Abbott Laboratories (2019-2024)
    Table 50. Abbott Laboratories Recent Developments
    Table 51. DiaSorin SpA Basic Information List
    Table 52. DiaSorin SpA Description and Business Overview
    Table 53. DiaSorin SpA Flu Diagnosis Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Flu Diagnosis Business of DiaSorin SpA (2019-2024)
    Table 55. DiaSorin SpA Recent Developments
    Table 56. Luminex Corporation Basic Information List
    Table 57. Luminex Corporation Description and Business Overview
    Table 58. Luminex Corporation Flu Diagnosis Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Flu Diagnosis Business of Luminex Corporation (2019-2024)
    Table 60. Luminex Corporation Recent Developments
    Table 61. Meridian Bioscience Basic Information List
    Table 62. Meridian Bioscience Description and Business Overview
    Table 63. Meridian Bioscience Flu Diagnosis Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Flu Diagnosis Business of Meridian Bioscience (2019-2024)
    Table 65. Meridian Bioscience Recent Developments
    Table 66. GenMark Diagnostics Basic Information List
    Table 67. GenMark Diagnostics Description and Business Overview
    Table 68. GenMark Diagnostics Flu Diagnosis Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Flu Diagnosis Business of GenMark Diagnostics (2019-2024)
    Table 70. GenMark Diagnostics Recent Developments
    Table 71. Sekisui Diagnostics Basic Information List
    Table 72. Sekisui Diagnostics Description and Business Overview
    Table 73. Sekisui Diagnostics Flu Diagnosis Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Flu Diagnosis Business of Sekisui Diagnostics (2019-2024)
    Table 75. Sekisui Diagnostics Recent Developments
    Table 76. Danaher Corporation Basic Information List
    Table 77. Danaher Corporation Description and Business Overview
    Table 78. Danaher Corporation Flu Diagnosis Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Flu Diagnosis Business of Danaher Corporation (2019-2024)
    Table 80. Danaher Corporation Recent Developments
    Table 81. Siemens Healthineers Basic Information List
    Table 82. Siemens Healthineers Description and Business Overview
    Table 83. Siemens Healthineers Flu Diagnosis Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Flu Diagnosis Business of Siemens Healthineers (2019-2024)
    Table 85. Siemens Healthineers Recent Developments
    Table 86. Cepheid Inc. Basic Information List
    Table 87. Cepheid Inc. Description and Business Overview
    Table 88. Cepheid Inc. Flu Diagnosis Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Flu Diagnosis Business of Cepheid Inc. (2019-2024)
    Table 90. Cepheid Inc. Recent Developments
    Table 91. Bio-Rad Laboratories, Inc. Basic Information List
    Table 92. Bio-Rad Laboratories, Inc. Description and Business Overview
    Table 93. Bio-Rad Laboratories, Inc. Flu Diagnosis Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Flu Diagnosis Business of Bio-Rad Laboratories, Inc. (2019-2024)
    Table 95. Bio-Rad Laboratories, Inc. Recent Developments
    Table 96. Key Raw Materials Lists
    Table 97. Raw Materials Key Suppliers Lists
    Table 98. Flu Diagnosis Downstream Customers
    Table 99. Flu Diagnosis Distributors List
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
    Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Flu Diagnosis Product Picture
    Figure 2. Global Flu Diagnosis Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Flu Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 4. Flu Diagnosis Report Years Considered
    Figure 5. Global Flu Diagnosis Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Flu Diagnosis Revenue in 2023
    Figure 7. Flu Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Traditional Diagnostic Tests Picture
    Figure 9. Molecular Diagnostic Tests Picture
    Figure 10. Other Picture
    Figure 11. Global Flu Diagnosis Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Flu Diagnosis Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Hospitals
    Figure 14. Product Picture of Clinical Laboratories
    Figure 15. Product Picture of Other
    Figure 16. Global Flu Diagnosis Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Flu Diagnosis Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Flu Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Flu Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Flu Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Flu Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Flu Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Flu Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Flu Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Flu Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Flu Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Flu Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Flu Diagnosis Sales Value (%), (2019-2030)
    Figure 29. United States Flu Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Flu Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Flu Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Flu Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Flu Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Flu Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Flu Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Flu Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Flu Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Flu Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Flu Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Flu Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Flu Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Flu Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Flu Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Flu Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Flu Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Flu Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Flu Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Flu Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Flu Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 50. Flu Diagnosis Industrial Chain
    Figure 51. Flu Diagnosis Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Infectious Disease Research Solutions Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2A19117
Fri Feb 21 00:00:00 UTC 2025

Add to Cart

Global Helicobacter Pylori Test Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27S9781
Tue Feb 18 00:00:00 UTC 2025

Add to Cart

Global Infectious Diseases Molecular Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10K9685
Tue Feb 18 00:00:00 UTC 2025

Add to Cart

Global Angio Seal Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N10613
Mon Feb 17 00:00:00 UTC 2025

Add to Cart